Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 17, 2026
TickeronGET DAILY SIGNALS
Why Is ReposiTrak (TRAK) Stock Down -8.25% Today?

Why Is ReposiTrak (TRAK) Stock Down -8.25% Today?

Key Takeaways

  • ReposiTrak (TRAK) shares fell 8.25% to $6.67 in early trading Tuesday, down $0.60 from Monday's $7.27 close.
  • The primary catalyst was a fiscal first-quarter earnings miss: EPS of $0.08 versus $0.10 expected, on revenue of $5.78 million that slipped 3% year over year.
  • Profitability deteriorated alongside the top line — operating income fell 12% to $1.7 million and operating margin compressed to 28.7% from 31.7%.
  • Secondary drivers included suspension of buybacks and preferred redemptions, negative operating cash flow of roughly $445,000, and a $2.7 million quarterly decline in cash to $24.5 million.
  • The company also unveiled a SPAR Group recapitalization that lifts its stake to about 49.99% as-converted, shifting balance-sheet assets into a lower-margin, labor-intensive merchandising business.
  • The selloff extends a long downtrend: the stock is roughly halved over twelve months and is trading near its 52-week low of $6.61.
  • News Significance Score: 50/100 — moderate fundamental deterioration met a decline nearly five times the stock's typical daily swing.
  • Investors can dig deeper into Price Targets, Earnings, and Forecast pages for additional detail on the name.
  • For systematic trading ideas, explore the curated Trending AI Robots section.

Opening Summary

ReposiTrak, Inc. (TRAK) is a Salt Lake City-based software-as-a-service provider whose AI-powered platform handles food traceability, supplier compliance and risk management, and retail supply chain operations for grocers, wholesalers and food manufacturers. Shares dropped 8.25% to $6.67 in Tuesday's opening session, compared with the prior close of $7.27, a decline of $0.60. The direction is unambiguously negative, and the catalyst is verified: the company reported fiscal first-quarter 2027 results after Monday's close, missing earnings expectations and posting a year-over-year revenue decline alongside margin compression and a strategic pivot toward a lower-margin affiliate.

Earnings Miss and Margin Compression

The fiscal quarter ended September 30 produced revenue of $5.78 million, down 3% from $5.97 million a year earlier, though up roughly $200,000 sequentially. Earnings per share came in at $0.08 basic and diluted versus $0.10 a year ago and against a consensus near $0.10, a shortfall of about 20%.

The quality of the print drew more scrutiny than the headline. Operating income fell 12% to $1.7 million and operating margin narrowed to 28.7% from 31.7%. General and administrative expense rose roughly 11% on higher personnel and benefit costs, while total operating costs edged up 1% after prior periods of aggressive cost cutting. A 68% drop in depreciation and amortization to $77,000 cushioned the reported result — a tailwind that will not repeat. Net income fell 16% to $1.5 million. With no numeric guidance issued, investors were left to weigh a qualitative promise of sequential improvement against a revenue line that has now declined for consecutive quarters.

FDA Deadline Extension Keeps Core Growth Under Pressure

Management attributed the revenue decline to the FDA's extension of its Food Traceability Rule enforcement date to July 2028, which has pushed customer purchasing decisions into later periods. For a compliance-driven software business, the deadline is the sales pitch; when it moves out more than two years, urgency evaporates. The cost base of roughly $4.1 million per quarter does not move with it. Management said traceability inquiries are rising again, but the revenue consequence now sits in fiscal 2028 and 2029 rather than the next four quarters.

Capital Returns Paused as Cash Generation Weakens

Operating cash flow swung to an outflow of about $445,000 from an inflow of $1.54 million a year earlier, driven by $1.6 million in cash taxes, a $1.09 million receivables build and a $920,000 reduction in accrued liabilities. Cash and equivalents fell to $24.5 million from $27.3 million at June 30, below the roughly $25 million level management had previously referenced. The company repurchased no shares and redeemed no preferred stock during the quarter, prioritizing the SPAR investment, and did not repeat earlier capital-return targets. Notes payable and finance leases rose to about $2.8 million from under $300,000, largely reflecting SPAR shares acquired with a promissory note.

SPAR Group Recapitalization Reshapes the Story

Announced alongside the quarter, the transaction would exchange ReposiTrak's roughly 8.9 million SGRP common shares and convert its $4.0 million note into a new SPAR preferred class at a common-equivalent price near $0.38, with anti-dilution protection, 50% warrant coverage and a new $1.5 million revolver. ReposiTrak would hold about 49.99% of SPAR on an as-converted basis.

The strategic logic — pairing software data with SPAR's in-store field force to power Touchless Retail — is real, and pilot results were strong, with a 17% sales lift at a dairy distributor and nearly 26% in greeting cards against a 5% target. But SPAR's most recent quarter showed net revenue down 19%, an 18.9% gross margin and a 0.7% operating margin. Investors are effectively being asked to accept a blend of 85%-gross-margin software economics with a shrinking, labor-intensive services business, plus rising single-partner concentration.

Market Context and Trading Activity

The decline is company-specific rather than sector-driven; there is no meaningful cluster of directly comparable traceability or compliance-software peers to drag the stock lower, and the move is far larger than anything in the broader market. Volume in the first minutes of the session was minimal, with only a few hundred shares changing hands against a 60-day average near 91,000, so the gap reflects repricing at the open rather than sustained institutional distribution. Technically, the stock gapped below its recent $7.00–$7.35 consolidation range and is pressing against its 52-week low of $6.61, a level that has acted as the floor for a twelve-month decline of roughly 50%. Market capitalization sits near $121 million.

News Significance Score

The scale runs from 0 — no meaningful news and a normal move for the stock — to 100, meaning transformative news paired with an extreme, rare price move. ReposiTrak earns 50 out of 100.

The verified news was moderate in strength: an earnings miss, a third consecutive revenue decline, margin compression and a pause in capital returns, all material for a company of this size but short of a transformative event. The price response was genuinely unusual. Today's 8.25% decline is roughly 4.9 times the stock's average absolute daily move of about 1.7% over the past 60 sessions, and no session in that window produced an equal or larger move. Solid news combined with a rare reaction produces a mid-range score rather than an extreme one.

What Comes Next for TRAK

Attention turns to fiscal second-quarter results, where management expects a six-figure Touchless Retail revenue contribution and sequential top-line improvement. Investors will want evidence that the roughly 20 pilots translate into durable rollouts rather than one-off tests. The FDA's 2028 compliance deadline remains the swing factor for the core traceability business, and any acceleration in inquiry conversion would be meaningful. Analysts currently carry a single consensus recommendation with limited coverage depth, so revisions may be sharp. Risks include further core revenue erosion, continued negative cash flow, execution risk on the SPAR recapitalization and the margin dilution it implies, and the possibility that buybacks and preferred redemptions stay suspended longer than expected. The absence of numeric guidance leaves the outlook unusually dependent on management commentary.

Trending AI Robots

Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions are surfaced in its curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the featured list changes as market conditions evolve. Reviewing that page can help traders see which automated approaches are working right now — and whether any of them fit their own risk parameters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TRAK

TRAK's Indicator enters downward trend

The Aroon Indicator for TRAK entered a downward trend on November 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 223 similar instances where the Aroon Indicator formed such a pattern. In 185 of the 223 cases the stock moved lower. This puts the odds of a downward move at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 58 cases where TRAK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TRAK as a result. In 64 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TRAK's RSI Indicator exited the oversold zone, 14 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.

The Moving Average Convergence Divergence (MACD) for TRAK just turned positive on November 09, 2026. Looking at past instances where TRAK's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

Following a +7.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRAK advanced for three days, in 212 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

TRAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.349) is normal, around the industry mean (-1.922). P/E Ratio (16.488) is within average values for comparable stocks, (9.599). Projected Growth (PEG Ratio) (0.140) is also within normal values, averaging (2.824). Dividend Yield (0.012) settles around the average of (0.069) among similar stocks. P/S Ratio (6.693) is also within normal values, averaging (70.699).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. TRAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.37B. The market cap for tickers in the group ranges from 39 to 269.45B. SAP holds the highest valuation in this group at 269.45B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -7%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -4%. VTSI experienced the highest price growth at 88%, while RCT experienced the biggest fall at -96%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 59
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 9 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of proprietary software products

Industry PackagedSoftware

Industry
Data Processing Services
Address
5282 South Commerce Drive
Phone
+1 435 645-2000
Employees
69
Web
https://www.repositrak.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.